417 related articles for article (PubMed ID: 11390412)
1. COX in a crystal ball: current status and future promise of prostaglandin research.
FitzGerald GA; Loll P
J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
[No Abstract] [Full Text] [Related]
2. Picture story. COX complexes.
Feng H
Nat Struct Biol; 2000 Jun; 7(6):448. PubMed ID: 10881188
[No Abstract] [Full Text] [Related]
3. Prostaglandin endoperoxide H synthases-1 and -2.
Smith WL; Dewitt DL
Adv Immunol; 1996; 62():167-215. PubMed ID: 8781269
[No Abstract] [Full Text] [Related]
4. [Progress in the study of cyclooxygenase].
Zhu H; Yang ZM
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
[No Abstract] [Full Text] [Related]
5. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
Vanegas H
Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
[No Abstract] [Full Text] [Related]
6. [COX-2 inhibitors: current status and outlook].
Dannhardt G; Hahn L
Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
Warner TD; Mitchell JA
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
[No Abstract] [Full Text] [Related]
8. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins.
Garavito RM; DeWitt DL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):278-87. PubMed ID: 10570255
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclo-oxygenase-2.
Stack E; DuBois RN
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041
[TBL] [Abstract][Full Text] [Related]
10. [A heterogenous drug class. NSAID: classification and spectrum of action].
Ulbrich H; Dannhardt G
Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
[No Abstract] [Full Text] [Related]
11. 1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors.
Biava M; Porretta GC; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Makovec F; Anzini M
J Med Chem; 2005 May; 48(9):3428-32. PubMed ID: 15857149
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for selective inhibition of COX-2 by nimesulide.
Fabiola GF; Pattabhi V; Nagarajan K
Bioorg Med Chem; 1998 Dec; 6(12):2337-44. PubMed ID: 9925294
[TBL] [Abstract][Full Text] [Related]
13. The structures of prostaglandin endoperoxide H synthases-1 and -2.
Garavito RM; Malkowski MG; DeWitt DL
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():129-52. PubMed ID: 12432914
[TBL] [Abstract][Full Text] [Related]
14. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
[TBL] [Abstract][Full Text] [Related]
15. Towards a better aspirin.
Vane J
Nature; 1994 Jan; 367(6460):215-6. PubMed ID: 8121485
[No Abstract] [Full Text] [Related]
16. Structural approach for COX-2 inhibition.
Michaux C; Charlier C
Mini Rev Med Chem; 2004 Aug; 4(6):603-15. PubMed ID: 15279594
[TBL] [Abstract][Full Text] [Related]
17. Closing in on a stomach-sparing aspirin substitute.
Service RF
Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
[No Abstract] [Full Text] [Related]
18. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
Marnett LJ; Rowlinson SW; Goodwin DC; Kalgutkar AS; Lanzo CA
J Biol Chem; 1999 Aug; 274(33):22903-6. PubMed ID: 10438452
[No Abstract] [Full Text] [Related]
19. Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy.
Onn A; Tseng JE; Herbst RS
Clin Cancer Res; 2001 Nov; 7(11):3311-3. PubMed ID: 11705841
[No Abstract] [Full Text] [Related]
20. Cyclooxygenase-2 inhibitors: promise or peril?
Mengle-Gaw LJ; Schwartz BD
Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
